Barclays Cuts American Healthcare REIT (AHR) Price Target to $60

Barclays has reiterated its Overweight rating on American Healthcare REIT, Inc. with a new price target of $60.00, a 13% upside from the current price.

By EarningsIQ Research Desk · Published Oct 16, 2026, 2:31 PM EDT

Reviewed by automated data checks against the source data. How we make and check alerts

Barclays cut its price target on American Healthcare REIT, Inc. ($AHR) to $60 from $66 on October 13, 2026, and rates the stock "Overweight".

Since the rating, $AHR is up 1.3% to date (from the $52.53 close on Oct 13, 2026).

AHR American Healthcare REIT, Inc.

$53.23 +14.37% year to date

Daily close · Oct 16, 2026

Key Points

On October 13, 2026, Barclays reiterated its Overweight rating on American Healthcare REIT, Inc. with a revised price target of $60.00, down from $66.00.
Barclays's $60 price target implies 13% upside from American Healthcare REIT, Inc.'s ($AHR) current $53.09 share price.
As of October 16, 2026, American Healthcare REIT, Inc. shares were recently trading at $53.09, which is about 1.1% above the $52.53 closing price on the event date.
The company has a market cap of approximately $11.6 billion and reported a revenue growth of 24.7% year-over-year.

Get $AHR trade alerts by text

We text you when insiders, Congress or big funds trade $AHR. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated American Healthcare REIT, Inc. alert may contain errors. Disclosures

On October 13, 2026, Barclays reiterated its Overweight rating on American Healthcare REIT, Inc. (AHR) and set a new price target of $60.00, down from $66.00. The stock closed at $52.53 on the same day.

Analyst rating track record

Barclays vs. the S&P 500

YTD return -0.09% hypothetical

All-time return -0.09% S&P 500 +0.36%

vs. S&P 500 -0.45% behind the index

Hypothetical returns from Barclays's disclosed trades, not real profit or advice. How we model this.

Barclays' Call on American Healthcare REIT, Inc.

Barclays maintained its Overweight rating on American Healthcare REIT, Inc., adjusting its price target from $66.00 to $60.00. This change reflects the firm's latest assessment of the company's performance and market conditions.

Other Institutional Activity in American Healthcare REIT, Inc.

Several other funds have shown activity in American Healthcare REIT, Inc. Blackrock Inc. reduced its holdings by 2,894,125 shares, ending with 25,845,948 shares worth about $1.38 billion. Vanguard Portfolio Management LLC increased its stake by 851,352 shares, bringing its total to 16,975,438 shares valued at roughly $903.9 million. Vanguard Capital Management LLC raised its position by 1,002,723 shares, now holding 9,201,599 shares worth about $490 million. Conversely, State Street Corporation trimmed its holdings by 499,216 shares, holding 9,046,025 shares valued at around $481.7 million. Principal Financial Group, Inc. grew its stake by 1,494,973 shares, resulting in a total of 8,917,875 shares worth about $474.9 million.

American Healthcare REIT, Inc. Stock Up 0.2%

American Healthcare REIT, Inc. shares were recently trading around $53.09 as of October 16, 2026. This price is about 1.1% above the $52.53 closing price from the event date. However, the stock is still about 16.6% below the mean price target of $63.69 set by analysts.

12-month forecast

$AHR price target

American Healthcare REIT, Inc. daily closes and this analyst's $60 target. Not advice.

Recent Earnings

American Healthcare REIT, Inc. reported trailing twelve-month revenue of $2.5 billion and an EPS of $0.67. The next earnings report is expected on November 5, 2026.

Insider Buying and Selling at American Healthcare REIT, Inc.

Recent insider transactions include General Counsel Mark E. Foster selling 2,500 shares at an average price of $48.58 on June 24, 2026, totaling $121,450. CFO Brian Scott Peay sold 25,000 shares at $50.70 on June 26, 2026, for about $1.27 million. Foster also sold 2,000 shares at $55.39 on September 1, 2026, valued at $110,780, and 1,500 shares at $52.06 on September 25, 2026, worth $78,090.

Analysts Set New Price Targets

On October 13, 2026, Barclays maintained its Overweight rating on American Healthcare REIT, Inc. with a target of $60.00. UBS also maintained its Buy rating with a target of $62.00 on the same day. The consensus among analysts is a strong buy rating, with a mean price target of $63.69 based on 16 opinions.

About American Healthcare REIT, Inc.

American Healthcare REIT, Inc. is a self-managed real estate investment trust (REIT) based in Maryland. The company owns and operates a diverse portfolio of healthcare real estate, including senior housing and skilled nursing facilities across the U.S., U.K., and the Isle of Man. This latest analyst rating reflects ongoing interest in the healthcare real estate sector.

Bottom Line

Investors should watch for American Healthcare REIT's upcoming earnings report on November 5, 2026. The recent adjustments in analyst ratings indicate a need to monitor the stock's performance against its targets, especially as it trades below the mean analyst price target.